Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).

Boston Scientific (BSX) announced the close of its acquisition of Axonics (AXNX). The purchase price of $71 cash per share represents an ...

Boston Scientific announced the acquisition in January, but the review timeline dragged on after the Federal Trade Commission ...

Axonics (NASDAQ:AXNX) quickly edged higher by 0.8% after a Nasdaq delisting notice for its planned sale to Boston Scientific ...

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January.

Additionally, Boston Scientific Corporation (NYSE:BSX) announced plans to acquire Axonics, reinforcing its commitment to boosting capacity and efficiency across key medical segments. On October 21 ...

马萨诸塞州马尔伯勒 - 波士顿科学公司(NYSE:BSX)今天宣布，已完成对专门从事泌尿和肠道功能障碍医疗设备的Axonics公司(NASDAQ:AXNX)的收购。该交易以每股71美元的价格成交，Axonics的股权价值约为37亿美元，企业价值为33亿美元。 预计此次收购对波士顿科学2024年和2025年的调整后每股收益影响将保持中性，之后预计会产生增值效应。在GAAP基础上，由于摊销费用和收购相 ...

Tomaso Zambelli, CEO of SoniVie, said "We look forward to benefiting from Mr. Cohen's broad experience in growing Medtech companies and moreover his expertise in renal denervation as we execute our ...

Marie Thibault, an analyst from BTIG, maintained the Buy rating on Boston Scientific (BSX – Research Report). The associated price target ...

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a ...

In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against the other hot growth stocks. A month before the election that spelled Donald Trump's ...

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: ...